A shutter shock image file of 131812463 with dna like image
Chrysalis BioTherapeutics receives $3 million grant for nuclear countermeasure development
GALVESTON, TX, May 2, 2016. Chrysalis BioTherapeutics, Inc. today announced receipt of a $3 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National…